Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Women With Early-Stage Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial
Clin. Cancer Res 2024 May 16;[EPub Ahead of Print], TC Haddad, VJ Suman, KV Giridhar, K Sideras, DW Northfelt, BJ Ernst, CC O'Sullivan, RJ Singh, Z Desta, PP Peethambaram, TJ Hobday, S Chumsri, RA Leon-Ferre, KJ Ruddy, S Yadav, JL Taraba, B Goodnature, MP Goetz, L Wang, JN IngleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.